United Parcel Service (UPS) stock looks attractive with a forward P/S of 0.97X, trading at a discount to the industry and S&P 500. Its Value Score is B, higher than rival FedEx’s A. UPS acquired Andlauer Healthcare for $1.6 billion, enhancing its healthcare logistics presence. The company offers a dividend yield of 6.5%.

UPS board approved a $5 billion share repurchase program in 2023. The company generated $6.3 billion in free cash flow in 2024. UPS has a strong earnings history, beating estimates in three of the past four quarters by an average of 11.2%. However, it faces challenges like low shipment volumes and international margin pressures.

Despite UPS’s positive aspects, challenges like tariff uncertainty and volume pressures remain. Investors may want to hold positions rather than initiate new ones. UPS stock has declined 21% in a year due to these challenges. It’s important to weigh these factors before making investment decisions.

Read more at Nasdaq: Is UPS’ Cheap Valuation Reason Enough to Invest in the Stock?